Furthermore, we confirmed this effect in C9orf72 patient-derived cells and human post-mortem cerebellum tissue from C9orf72 mutation positive ALS/ FTD patients showing reduced expression levels of proteins with high Phe content. This evidence concerns the gene C9orf72 and frontotemporal dementia.